XML 90 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Collaborations - BeiGene (Details) - USD ($)
12 Months Ended
Jan. 02, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenue from Contract with Customer, Including Assessed Tax   $ 26,323,000,000 $ 25,979,000,000 $ 25,424,000,000
BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross $ 1,250,000,000      
BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Equity Method Investment, Aggregate Cost $ 2,800,000,000      
Other current assets [Member] | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Related Party Transaction, Due from (to) Related Party   47,000,000 61,000,000  
Trade Accounts Receivable | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Related Party Transaction, Due from (to) Related Party   6,000,000 21,000,000  
Research and Development Expense [Member] | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Cost recoveries   199,000,000 220,000,000 $ 225,000,000
Selling, general and administrative [Member] | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Profit and loss share of expenses   53,000,000 64,000,000  
BeiGene | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenue from Contract with Customer, Including Assessed Tax   $ 64,000,000 $ 72,000,000